Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Meyer

Showing results (441-450 of 510) with videos related to

Pageof 51
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2016
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular CarcinomaJulien Edeline, Jean-Frédéric Blanc, Philip Johnson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 8, 2020
The glucocorticoid-induced leucine zipper mediates statin-induced muscle damageJessica Hoppstädter, Jenny Vanessa Valbuena Perez, Rebecca Linnenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2022
Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine TumorsClare Vesely, Yien Ning Sophia Wong, Alexa Childs, et al.
British Journal of Cancer|January 15, 2019
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumoursFrancesca M Rizzo, Clare Vesely, Alexa Childs, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 5, 2014
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteriaIoanna Parisi, Emmanuel Tsochatzis, Hasitha Wijewantha, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2026
Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomesGloryanne Aidoo-Micah, Stephanie Kucykowicz, Nathalie Schmidt, et al.
Liver Cancer|February 28, 2022
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaLorenza Rimassa, Robin Kate Kelley, Tim Meyer, et al.
World Journal of Gastroenterology|October 30, 2019
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centresMelissa Frizziero, Xin Wang, Bipasha Chakrabarty, et al.
BMJ Open|February 8, 2020
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC)Zoe Craig, Jayne Swain, Emma Batman, et al.
British Journal of Cancer|January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasionImam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Pageof 51

Showing results (441-450 of 510) with videos related to

Sort By:
Pageof 51
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2016
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular CarcinomaJulien Edeline, Jean-Frédéric Blanc, Philip Johnson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 8, 2020
The glucocorticoid-induced leucine zipper mediates statin-induced muscle damageJessica Hoppstädter, Jenny Vanessa Valbuena Perez, Rebecca Linnenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2022
Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine TumorsClare Vesely, Yien Ning Sophia Wong, Alexa Childs, et al.
British Journal of Cancer|January 15, 2019
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumoursFrancesca M Rizzo, Clare Vesely, Alexa Childs, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 5, 2014
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteriaIoanna Parisi, Emmanuel Tsochatzis, Hasitha Wijewantha, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2026
Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomesGloryanne Aidoo-Micah, Stephanie Kucykowicz, Nathalie Schmidt, et al.
Liver Cancer|February 28, 2022
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaLorenza Rimassa, Robin Kate Kelley, Tim Meyer, et al.
World Journal of Gastroenterology|October 30, 2019
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centresMelissa Frizziero, Xin Wang, Bipasha Chakrabarty, et al.
BMJ Open|February 8, 2020
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC)Zoe Craig, Jayne Swain, Emma Batman, et al.
British Journal of Cancer|January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasionImam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Pageof 51